IRCT20220209053979N5尚未招募未知
Bioequivalence Study of amlodipine valsartan 10/160 mg manufactured by Alborz Darou and Exforge manufactured by Novartis in 24 Healthy Volunteers
Alborz Darou0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Laboratory tests +/- 10% of normal interval
- •without any history of chronic sickness
排除标准
- •Systolic blood pressure less than 90 and diastolic less than 60 mm Hg
- •Smoking more than 10 cigarette per day
研究者
相似试验
招募中
Unknown
Bioequivalence study of Amlodipine/Valsartan tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N54Tabriz University of Medical Sciences24
已完成
不适用
Comparative in vivo evaluation of 2 Amlodipine 10/Valsartan160 mg Tablet formulations.IRCT20180620040164N36Karen Pharma and Food Supplement Co.24
招募中
不适用
Bioequivalence study of Amlodipine 10 mg + Valsartan 160 mg film coated tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Actover. Amlodipine 10 mg + Valsartan 160 mg film coated tablet with brand EXFORGE® NOVARTIS Tablet..IRCT20180620040164N20Actover Pharmaceutical Co.24
尚未招募
不适用
Bioequivalence study of Valsartan 160 mg tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Karen Pharma and Food Supplement Co. Valsartan 160 mg tablet with brand Diovan® 160 mg tablet Novartis pharmaceuticals...IRCT20180620040164N18Karen Pharma and Food Supplement Co.24
已完成
不适用
Bioequivalence study of Valsartan 160 mgHealthy volunteers.IRCT20200623047902N5Sanamed pharma company24